Pharmacokinetics and biodistribution of itraconazole in rats and mice following intravenous administration in a novel liposome formulation

Drug Delivery

Volumn 17, Issue 4, 2010, Pages 223-230

  Tang, Jingling ^a   Wei, Hua ^a   Liu, Hongmei ^a   Ji, Hongyu ^a   Dong, Di ^a   Zhu, Daling ^a   Wu, Linhua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Itraconazole; Liposomes; Pharmacokinetics; Tissue distribution

Indexed keywords

ITRACONAZOLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; INJECTIONS, INTRAVENOUS; ITRACONAZOLE; LIPOSOMES; MALE; MICE; RATS; RATS, WISTAR; SPECIES SPECIFICITY; TISSUE DISTRIBUTION;

EID: 77951484424     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717541003667822     Document Type: Article

References (12)

1. Chen, W., Gu, B., Wang, H., Pan, J., Lu, W., Hou, H. (2008). Development and evaluation of novel itraconazole-loaded intravenous nanoparticles. Int J Pharm. 362:133-140
2. Edwards, J.E., Bodey, G.P., Bowden, R.A., Buchner, T., de Pauw, B.E., Filler, S.G., Ghannoum, M.A., Glauser, M., Herbrecht, R., Kauffman, C.A., Kohno, S., Martino, P., Meunier, F., Mori, T., Pfaller, M.A., Rex, J.H., Rogers, T.R., Rubin, R.H., Solomkin, J., Viscoli, C., Walsh, T.J., White, M. (1997). International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis. 25:43-59.
3. Groll, A.H., Wood, L., Roden, M., Mickiene, D., Chiou, C.C., Townley, E., Dad, L., Piscitelli, S.C., Walsh, T.J. (2002). Safety, pharmacokinetics and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasis. Antimicrob Agents Chemother. 46:2554-2563
4. Jung, J.Y., Yoo, S.D., Lee, S.H., Kim, K.H., Yoon, D.S., Lee, K.H. (1999). Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique. Int J Pharm. 187:209-218
5. Rabinow, B., Kipp, J., Papadopoulos, P., Wong, J., Glosson, J., Gass, J., Sun, C.S., Wielgos, T., White, R., Cook, C., Barker, K., Wood, K. (2007). Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int J Pharm. 339:251-260
6. Rex, J., Pfaller, M., Galgiani, J., Bartlett, M.S., Espinel-Ingroff, A., Ghannoum, M.A., Lancaster, M., Odds, F.C., Rinaldi, M.G., Walsh, T.J., Barry, A.L. (1997). Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and Candida infections. Clin Infect Dis. 24:235-247 (Pubitemid 127774263)
7. Rhee, Y.S., Park, C.W., Nam, T.Y., Shin, Y.S., Chi, S.C., Park, E.S. (2007). Formulation of parenteral microemulsion containing itraconazole. Arch Pharm Res. 30:114-123
8. Thomson, P.D.R., Montvale, N.J. (2005). Physician's Desk Reference, 59th ed., 2005. Thomson PDR, Montvale, NJ, pp. 1757-1766
9. Van Cauteren, H., Heykants, J., De Coster, R., Cauwenbergh, G. (1987). Itraconazole: pharmacologic studies in animals and humans. Rev Infect Dis. 9:S43-6.
10. Walsh, J., Teppler, H., Donowitz, G.R., Maertens, J.A., Baden, L.R., Dmoszynska, A., Cornely, O.A., Bourque, M.R., Lupinacci, R.J., Sable, C.A., dePauw, B.E. (2004). Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 351:1391-1402
11. Yamashita, C., Matsuo, H., Akiyama, K., Kiwada, H. (1991). Enhancing effect of cetylmannoside on targeting of liposomes to Kupffer cells in rats. Int J Pharm. 70:225-233
12. Yi, Y., Yoon, H.J., Kim, B.O., Shim, M., Kim, S.O., Hwang, S.J., Seo, M.H. (2007). A mixed polymeric micellar formulation of itraconazole: characteristics, toxicity and pharmacokinetics. J Contr Rel. 117:59-67.